Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication

Kazushi Tamura, Atsushi Oue, Atsushi Tanaka, Nobuaki Shimizu, Hitoshi Takagi, Nobuyuki Kato, Akihiro Morikawa, Hiroo Hoshino

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in addition to acute hepatitis. The HCV genome encodes two envelope glycoproteins, E1 and E2. To investigate the role of E1 and E2 in HCV infection, we used a recombinant vesicular stomatitis virus (VSV), VSVΔG*, harboring the green fluorescent protein gene instead of the VSV G envelope protein gene. It was complemented with the native form of E1 and E2, or E1 or E2 alone, to make HCV pseudotypes VSVΔG*(HCV), VSVΔG*(E1), and VSVΔG*(E2). Neither E1 nor E2 expression was detected on the cell surface, as reported. Unlike previous reports, infectious activities of VSVΔG*(HCV), VSVΔG*(E1) and VSVΔG*(E2) pseudotypes were detected under conditions where VSV was completely neutralized by anti-VSV. We could enhance the infectious titers 100-fold by sonication upon virus harvest. Bovine lactoferrin efficiently inhibited infection by VSVΔG*(HCV) as well as VSVΔG*(E2) , as the interaction between E2 and lactoferrin has been thought to contribute to the inhibition of HCV infectivity. VSVΔG*(HCV) infected many adherent cell lines, including hepatic cell lines, but not most hematopoietic cell lines. Treatment of cells with trypsin, tunicamycin, or sulfated polysaccharides before infection reduced the infectivity of VSVΔG* (HCV) by about 90%, suggesting that a cell surface protein(s) with sugar chains plays an important role in HCV infection. The VSV pseudotypes developed here would be useful for analyzing the early stages of HCV infection.

Original languageEnglish
Pages (from-to)29-40
Number of pages12
JournalMicrobes and Infection
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Viral Envelope Proteins
Vesicular Stomatitis
Sonication
Hepacivirus
Viruses
Virus Diseases
Lactoferrin
Cell Line
Tunicamycin
Chronic Hepatitis
Green Fluorescent Proteins
Infection
Liver Cirrhosis
Trypsin
Hepatitis
Genes
Polysaccharides
Hepatocytes
Hepatocellular Carcinoma
Glycoproteins

Keywords

  • Envelope
  • Glycosylation
  • HCV
  • Pseudotype
  • Sonication

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication. / Tamura, Kazushi; Oue, Atsushi; Tanaka, Atsushi; Shimizu, Nobuaki; Takagi, Hitoshi; Kato, Nobuyuki; Morikawa, Akihiro; Hoshino, Hiroo.

In: Microbes and Infection, Vol. 7, No. 1, 01.2005, p. 29-40.

Research output: Contribution to journalArticle

Tamura, Kazushi ; Oue, Atsushi ; Tanaka, Atsushi ; Shimizu, Nobuaki ; Takagi, Hitoshi ; Kato, Nobuyuki ; Morikawa, Akihiro ; Hoshino, Hiroo. / Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication. In: Microbes and Infection. 2005 ; Vol. 7, No. 1. pp. 29-40.
@article{f15620cc908f4ec5900dfaf8f2532af8,
title = "Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication",
abstract = "Hepatitis C virus (HCV) causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in addition to acute hepatitis. The HCV genome encodes two envelope glycoproteins, E1 and E2. To investigate the role of E1 and E2 in HCV infection, we used a recombinant vesicular stomatitis virus (VSV), VSVΔG*, harboring the green fluorescent protein gene instead of the VSV G envelope protein gene. It was complemented with the native form of E1 and E2, or E1 or E2 alone, to make HCV pseudotypes VSVΔG*(HCV), VSVΔG*(E1), and VSVΔG*(E2). Neither E1 nor E2 expression was detected on the cell surface, as reported. Unlike previous reports, infectious activities of VSVΔG*(HCV), VSVΔG*(E1) and VSVΔG*(E2) pseudotypes were detected under conditions where VSV was completely neutralized by anti-VSV. We could enhance the infectious titers 100-fold by sonication upon virus harvest. Bovine lactoferrin efficiently inhibited infection by VSVΔG*(HCV) as well as VSVΔG*(E2) , as the interaction between E2 and lactoferrin has been thought to contribute to the inhibition of HCV infectivity. VSVΔG*(HCV) infected many adherent cell lines, including hepatic cell lines, but not most hematopoietic cell lines. Treatment of cells with trypsin, tunicamycin, or sulfated polysaccharides before infection reduced the infectivity of VSVΔG* (HCV) by about 90{\%}, suggesting that a cell surface protein(s) with sugar chains plays an important role in HCV infection. The VSV pseudotypes developed here would be useful for analyzing the early stages of HCV infection.",
keywords = "Envelope, Glycosylation, HCV, Pseudotype, Sonication",
author = "Kazushi Tamura and Atsushi Oue and Atsushi Tanaka and Nobuaki Shimizu and Hitoshi Takagi and Nobuyuki Kato and Akihiro Morikawa and Hiroo Hoshino",
year = "2005",
month = "1",
doi = "10.1016/j.micinf.2004.09.006",
language = "English",
volume = "7",
pages = "29--40",
journal = "Microbes and Infection",
issn = "1286-4579",
publisher = "Elsevier Masson SAS",
number = "1",

}

TY - JOUR

T1 - Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication

AU - Tamura, Kazushi

AU - Oue, Atsushi

AU - Tanaka, Atsushi

AU - Shimizu, Nobuaki

AU - Takagi, Hitoshi

AU - Kato, Nobuyuki

AU - Morikawa, Akihiro

AU - Hoshino, Hiroo

PY - 2005/1

Y1 - 2005/1

N2 - Hepatitis C virus (HCV) causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in addition to acute hepatitis. The HCV genome encodes two envelope glycoproteins, E1 and E2. To investigate the role of E1 and E2 in HCV infection, we used a recombinant vesicular stomatitis virus (VSV), VSVΔG*, harboring the green fluorescent protein gene instead of the VSV G envelope protein gene. It was complemented with the native form of E1 and E2, or E1 or E2 alone, to make HCV pseudotypes VSVΔG*(HCV), VSVΔG*(E1), and VSVΔG*(E2). Neither E1 nor E2 expression was detected on the cell surface, as reported. Unlike previous reports, infectious activities of VSVΔG*(HCV), VSVΔG*(E1) and VSVΔG*(E2) pseudotypes were detected under conditions where VSV was completely neutralized by anti-VSV. We could enhance the infectious titers 100-fold by sonication upon virus harvest. Bovine lactoferrin efficiently inhibited infection by VSVΔG*(HCV) as well as VSVΔG*(E2) , as the interaction between E2 and lactoferrin has been thought to contribute to the inhibition of HCV infectivity. VSVΔG*(HCV) infected many adherent cell lines, including hepatic cell lines, but not most hematopoietic cell lines. Treatment of cells with trypsin, tunicamycin, or sulfated polysaccharides before infection reduced the infectivity of VSVΔG* (HCV) by about 90%, suggesting that a cell surface protein(s) with sugar chains plays an important role in HCV infection. The VSV pseudotypes developed here would be useful for analyzing the early stages of HCV infection.

AB - Hepatitis C virus (HCV) causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in addition to acute hepatitis. The HCV genome encodes two envelope glycoproteins, E1 and E2. To investigate the role of E1 and E2 in HCV infection, we used a recombinant vesicular stomatitis virus (VSV), VSVΔG*, harboring the green fluorescent protein gene instead of the VSV G envelope protein gene. It was complemented with the native form of E1 and E2, or E1 or E2 alone, to make HCV pseudotypes VSVΔG*(HCV), VSVΔG*(E1), and VSVΔG*(E2). Neither E1 nor E2 expression was detected on the cell surface, as reported. Unlike previous reports, infectious activities of VSVΔG*(HCV), VSVΔG*(E1) and VSVΔG*(E2) pseudotypes were detected under conditions where VSV was completely neutralized by anti-VSV. We could enhance the infectious titers 100-fold by sonication upon virus harvest. Bovine lactoferrin efficiently inhibited infection by VSVΔG*(HCV) as well as VSVΔG*(E2) , as the interaction between E2 and lactoferrin has been thought to contribute to the inhibition of HCV infectivity. VSVΔG*(HCV) infected many adherent cell lines, including hepatic cell lines, but not most hematopoietic cell lines. Treatment of cells with trypsin, tunicamycin, or sulfated polysaccharides before infection reduced the infectivity of VSVΔG* (HCV) by about 90%, suggesting that a cell surface protein(s) with sugar chains plays an important role in HCV infection. The VSV pseudotypes developed here would be useful for analyzing the early stages of HCV infection.

KW - Envelope

KW - Glycosylation

KW - HCV

KW - Pseudotype

KW - Sonication

UR - http://www.scopus.com/inward/record.url?scp=15944412810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944412810&partnerID=8YFLogxK

U2 - 10.1016/j.micinf.2004.09.006

DO - 10.1016/j.micinf.2004.09.006

M3 - Article

C2 - 15716060

AN - SCOPUS:15944412810

VL - 7

SP - 29

EP - 40

JO - Microbes and Infection

JF - Microbes and Infection

SN - 1286-4579

IS - 1

ER -